Surbana Jurong clinches coveted Hyderabad Pharma City contract in India
Months of effort have culminated in a remarkable victory after the Surbana Jurong Group won the contract for a pharmaceutical facility project in India.
Telangana State Industrial Infrastructure Corporation awarded SJ the master planning consultancy as well as detailed infrastructure engineering and building design work for the Pharma City project in Hyderabad. The planned state-of-the-art pharmaceutical facility is the first and largest of its kind in South Asia for the pharma industry.The project is to come up on over 14,000 acres in Mucherla and surrounding villages in Ranga Reddy and Mahabubnagar districts.
With our integrated suite of services, SJ beat the competition from various international and Indian firms to win the project.
“We have been actively pursuing the Hyderabad Pharma City project and after eight months of effort, we are proud to be awarded this very important project. It is one of its kind in India and the Hyderabad government has plans for this to become a world-class Pharma manufacturing hub with smart infrastructure solutions.” said Mr Teo Eng Cheong, CEO (International), Surbana Jurong.
Mr Teo Eng Cheong also met with Telangana’sMinister for Information Technology, Industries, Municipal Administration and Urban Development K T Rama Rao when Mr Rama Rao visited Singapore earlier in June to bolster confidence in our capabilities. The meeting signaled strong support from the SJ management and positively contributed to the win.
Created just two years ago, Telangana is India’s newest state and its government is keen to attract huge investments. Telangana’s capital city of Hyderabad is known to be India’sPharma capitalwith about 40% of India’s total drug production.
Type of Project: Master Planning, Detailed Infrastructure Engineering and Building Designs
Size: 14,000 acres
Status: Awarded in October 2016. Project targeted for completion in June 2017
Significance: India’s first National Investment Manufacturing Zone, largest such facility in South Asia for the Pharma Industry